InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 331817

Monday, 10/28/2019 8:00:55 AM

Monday, October 28, 2019 8:00:55 AM

Post# of 345952
Anita Kavlie .. and others, including Wayne Gombotz KNOW PS Targeting required as patents filed with key players and some sing from Omeros that just published PS Targeting is required

Jay Venkatesan over at Alpine Immune Sciences...remember him from Ayer Capital Management ? : ) ...with Al Gore sidekick and they were forced to close due to illegal trading of Peregrine Pharmaceuticals and now in the midst of PS Targeting .....like Hotel California no one leaves

MORE to come...I can promise that and ex Omeros Clark E Tedford can't even deny the protein pathways that PROVE PS Targeting required

________

Compositions for Inhibiting MASP-2 Dependent Complement Activation
Publication number: 20190119402
Abstract: The present invention relates to anti-MASP-2 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-2 dependent complement activation.

Type: Application

Filed: July 13, 2018
Publication date: April 25, 2019

Inventors:

Thomas Dudler,
Wayne R. Gombotz,
James Brian Parent,
Clark E. Tedford,
Anita Kavlie,
Urs Beat Hagemann,
Herald Reiersen,
Sergej Kiprijanov


https://patents.justia.com/inventor/anita-kavlie

________

Wayne Gombotz

Chief Technology Officer at Alpine Immune Sciences
Alpine Immune Sciences
University of Washington
Seattle, Washington

Experience
Alpine Immune Sciences
Chief Technology Officer
Alpine Immune Sciences
Jun 2019 – Present5 months
Greater Seattle Area

Alpine Immune Sciences
Chief Technology Officer
Alpine Immune Sciences
Jun 2019 – Present5 months
Greater Seattle Area
Immune Design
Chief Development Officer
Immune Design
Oct 2011 – Present8 years 1 month
Seattle, WA

Omeros Corporation
Vice President Pharmaceutical Operations
Omeros Corporation
2005 – 2011
6 years
Seattle, WA

Corixa Corp.
Vice President Process Science & Pharmaceutical Development
Corixa Corp.
Sep 2002 – Mar 2005
2 years 7 months

Immunex Corp
Sr. Director Analytical Chemistry & Formulation
Immunex Corp
1993 – 20029 years
Bristol-Myers Squibb
Sr. Research Investigator
Bristol-Myers Squibb
1990 – 19933 years
Greater Seattle Area

Enzytech, Inc.
Research Scientist
Enzytech, Inc.
1988 – 19902 years
Cambridge, MA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News